首页 > 最新文献

International Journal of Vascular Medicine最新文献

英文 中文
Age and Gender Difference in the Association of Metabolic Syndrome and Peripheral Artery Disease Among Patients With Type 2 Diabetes Mellitus. 2型糖尿病患者代谢综合征与外周动脉疾病相关性的年龄和性别差异
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-03-10 eCollection Date: 2025-01-01 DOI: 10.1155/ijvm/5572344
Xiaotong Feng, Yongsong Xu, Lin Zhu, Kun Li, Lin Mao, Huan Dong, Dong Zhao, Jing Ke

Purpose: Our study is aimed at exploring the association between peripheral artery disease (PAD) and metabolic syndrome (MetS) across different age and gender groups among patients with Type 2 diabetes mellitus (T2DM). Patients and Methods: A total of 3638 patients with T2DM were enrolled in the study, including 281 patients with PAD and 3357 patients without PAD. Demographic data and anthropometric measurements, such as height, weight, and waist circumference, were collected. Laboratory tests and ankle-brachial index (ABI) assessment were also conducted. Multiple logistic regression was used to evaluate the relationship between PAD and the number of MetS components across different age and gender groups. Results: After adjusting for potential confounding factors, our results indicated that the ORs for the presence of PAD increased progressively with the number of MetS components. Stratified analysis showed that this effect was particularly pronounced in younger patients (aged < 40 years) and older patients (aged ≥ 60 years), where the risk of PAD rose with an increasing number of MetS components. Furthermore, the positive association between the number of MetS components and PAD presence was significantly stronger in females. Conclusions: In summary, our findings suggest that the risk of PAD is positively correlated with the number of MetS components in patients with T2DM, especially among younger patients and older patients. Additionally, the positive association between the number of MetS components and the presence of PAD was significantly more evident in female patients.

目的:本研究旨在探讨不同年龄和性别的2型糖尿病(T2DM)患者外周动脉疾病(PAD)与代谢综合征(MetS)之间的关系。患者和方法:共有3638例T2DM患者入组,其中PAD患者281例,非PAD患者3357例。收集了人口统计数据和人体测量数据,如身高、体重和腰围。还进行了实验室检查和踝臂指数(ABI)评估。采用多元逻辑回归评估不同年龄和性别人群中PAD与MetS成分数量之间的关系。结果:在调整了潜在的混杂因素后,我们的结果表明,随着MetS组件的数量增加,PAD存在的or逐渐增加。结论:总之,我们的研究结果表明,PAD的风险与T2DM患者中MetS成分的数量呈正相关,尤其是在年轻患者和老年患者中。此外,MetS成分数量与PAD存在之间的正相关在女性患者中更为明显。
{"title":"Age and Gender Difference in the Association of Metabolic Syndrome and Peripheral Artery Disease Among Patients With Type 2 Diabetes Mellitus.","authors":"Xiaotong Feng, Yongsong Xu, Lin Zhu, Kun Li, Lin Mao, Huan Dong, Dong Zhao, Jing Ke","doi":"10.1155/ijvm/5572344","DOIUrl":"https://doi.org/10.1155/ijvm/5572344","url":null,"abstract":"<p><p><b>Purpose:</b> Our study is aimed at exploring the association between peripheral artery disease (PAD) and metabolic syndrome (MetS) across different age and gender groups among patients with Type 2 diabetes mellitus (T2DM). <b>Patients and Methods:</b> A total of 3638 patients with T2DM were enrolled in the study, including 281 patients with PAD and 3357 patients without PAD. Demographic data and anthropometric measurements, such as height, weight, and waist circumference, were collected. Laboratory tests and ankle-brachial index (ABI) assessment were also conducted. Multiple logistic regression was used to evaluate the relationship between PAD and the number of MetS components across different age and gender groups. <b>Results:</b> After adjusting for potential confounding factors, our results indicated that the ORs for the presence of PAD increased progressively with the number of MetS components. Stratified analysis showed that this effect was particularly pronounced in younger patients (aged < 40 years) and older patients (aged ≥ 60 years), where the risk of PAD rose with an increasing number of MetS components. Furthermore, the positive association between the number of MetS components and PAD presence was significantly stronger in females. <b>Conclusions:</b> In summary, our findings suggest that the risk of PAD is positively correlated with the number of MetS components in patients with T2DM, especially among younger patients and older patients. Additionally, the positive association between the number of MetS components and the presence of PAD was significantly more evident in female patients.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2025 ","pages":"5572344"},"PeriodicalIF":2.5,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11991799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144001098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Objective Assessment of the Cardiorespiratory Fitness Among Individuals With Lymphedema and Lipedema: A Systematic Review and Meta-Analysis. 目的评价淋巴水肿和脂水肿患者的心肺健康:系统回顾和荟萃分析。
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-13 eCollection Date: 2025-01-01 DOI: 10.1155/ijvm/8627520
Amirparsa Vanaki, Amirhossein Fallah, Negin Rahimidanesh, Arian Ashnaei, Mohammad Mahdi Naghadian Moghaddam, Mohammad Shahrabi Farahani, Masood Soltanipur, Hossein Yarmohammadi

Background: One of the main challenges in managing lymphedema and lipedema is the lack of valid and reliable objective measures for diagnosis and follow-up. This study was aimed at gathering evidence regarding the objective measures of cardiorespiratory fitness (CRF) among these populations. Methods: Scopus, PubMed, and Embase were searched for observational studies investigating the objective measures of CRF among individuals with lipedema and lymphedema. Both primary and secondary lymphedema were included. Different CRF measures reported by the included articles were determined, and the main outcomes regarding these measurements were extracted. The meta-analysis was performed to compare the pooled mean 6-min walk test (6MWT) between individuals with lower limb lymphedema and lipedema using STATA software (Version 17.0). Results: Eight articles were included, and the majority of participants were female. Four distinct objective measures of CRF were reported among the included articles, including hemodynamic indices, spirometry indices, VO2 peak, and 6MWT. The mean VO2 peak was significantly lower among women with breast cancer-related lymphedema; however, there was no correlation between affected limb volumes and the VO2 peak. The meta-analysis revealed a lower mean 6MWT among individuals with lipedema compared to lymphedema (pooled difference: 37.71 [confidence interval (CI): 5.19-70.22], p value: 0.02, I 2: 0%). Also, there was a significant relationship between 6MWT and subjective measures of CRF, such as the Short Form 36 (SF-36) physical function score, in one included article. Conclusion: While limited evidence exists on the objective measures of CRF among individuals with lymphedema and lipedema, there might be a significant difference in 6MWT between these two groups.

背景:管理淋巴水肿和脂水肿的主要挑战之一是缺乏有效和可靠的客观诊断和随访措施。本研究旨在收集有关这些人群中心肺健康(CRF)客观测量的证据。方法:检索Scopus、PubMed和Embase中关于脂水肿和淋巴水肿患者CRF客观测量的观察性研究。包括原发性和继发性淋巴水肿。我们确定了被纳入文章报道的不同CRF测量值,并提取了这些测量值的主要结果。采用STATA软件(Version 17.0)进行meta分析,比较下肢淋巴水肿和脂质水肿患者的合并平均6分钟步行测试(6MWT)。结果:共纳入8篇文章,受试者以女性居多。在纳入的文章中,报告了四种不同的客观CRF测量方法,包括血流动力学指标、肺活量测定指标、VO2峰值和6MWT。患有乳腺癌相关淋巴水肿的女性的平均VO2峰值明显较低;然而,患肢体积与VO2峰值之间没有相关性。荟萃分析显示,与淋巴水肿患者相比,脂肪水肿患者的平均6MWT较低(总差值:37.71[置信区间(CI): 5.19-70.22], p值:0.02,0.2%)。此外,在一篇纳入的文章中,6MWT与CRF的主观测量指标(如SF-36身体功能评分)之间存在显著关系。结论:虽然在淋巴水肿和脂质水肿患者中CRF的客观测量证据有限,但两组之间的6MWT可能存在显著差异。
{"title":"Objective Assessment of the Cardiorespiratory Fitness Among Individuals With Lymphedema and Lipedema: A Systematic Review and Meta-Analysis.","authors":"Amirparsa Vanaki, Amirhossein Fallah, Negin Rahimidanesh, Arian Ashnaei, Mohammad Mahdi Naghadian Moghaddam, Mohammad Shahrabi Farahani, Masood Soltanipur, Hossein Yarmohammadi","doi":"10.1155/ijvm/8627520","DOIUrl":"10.1155/ijvm/8627520","url":null,"abstract":"<p><p><b>Background:</b> One of the main challenges in managing lymphedema and lipedema is the lack of valid and reliable objective measures for diagnosis and follow-up. This study was aimed at gathering evidence regarding the objective measures of cardiorespiratory fitness (CRF) among these populations. <b>Methods:</b> Scopus, PubMed, and Embase were searched for observational studies investigating the objective measures of CRF among individuals with lipedema and lymphedema. Both primary and secondary lymphedema were included. Different CRF measures reported by the included articles were determined, and the main outcomes regarding these measurements were extracted. The meta-analysis was performed to compare the pooled mean 6-min walk test (6MWT) between individuals with lower limb lymphedema and lipedema using STATA software (Version 17.0). <b>Results:</b> Eight articles were included, and the majority of participants were female. Four distinct objective measures of CRF were reported among the included articles, including hemodynamic indices, spirometry indices, VO<sub>2</sub> peak, and 6MWT. The mean VO<sub>2</sub> peak was significantly lower among women with breast cancer-related lymphedema; however, there was no correlation between affected limb volumes and the VO<sub>2</sub> peak. The meta-analysis revealed a lower mean 6MWT among individuals with lipedema compared to lymphedema (pooled difference: 37.71 [confidence interval (CI): 5.19-70.22], <i>p</i> value: 0.02, <i>I</i> <sup>2</sup>: 0%). Also, there was a significant relationship between 6MWT and subjective measures of CRF, such as the Short Form 36 (SF-36) physical function score, in one included article. <b>Conclusion:</b> While limited evidence exists on the objective measures of CRF among individuals with lymphedema and lipedema, there might be a significant difference in 6MWT between these two groups.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2025 ","pages":"8627520"},"PeriodicalIF":2.5,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143483062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Long-Term Progression of Aneurysmal Disease in Common Iliac Arteries After Standard EVAR and Its Clinical Implications. 标准EVAR术后髂总动脉动脉瘤疾病的长期进展及其临床意义。
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-29 eCollection Date: 2024-01-01 DOI: 10.1155/ijvm/4229582
Apostolos G Pitoulias, Dimitrios Chatzelas, Matthaios G Pitoulias, Loukia A Politi, Dimitrios C Christopoulos, Ioannis Lazaridis, Nikolaos Saratzis, Georgios A Pitoulias

Introduction: The progression of aneurysmal disease in the common iliac arteries (CIAs) after EVAR remains an insufficiently investigated field. The purpose of this study is to investigate the long-term outcomes of standard elective EVAR with a variety of last-generation bifurcated aortic endografts in relation with the progression of aneurysmal disease in the CIAs. Methods: This is a prospective cohort study of 168 patients, who were treated with six different endografts between 2013 and 2018 and completed the 5-year computed tomography aortoangiography (CTA) follow-up. Postoperative CTA analysis included CIA measurements at four diameters' points and two length levels in three postoperative time spots: first, 24th, and 60th months. All EVAR-related adverse events were recorded, including migrations, endoleaks, limb occlusions, reinterventions, ruptures, and mortality. Results: At both time intervals, a significant and nearly linear dilatation and elongation of CIAs was evident. The mean percent increase, among all diameter points measured, was 11.7% at 24 months and 22.8% at 60 months (p < 0.001) with a nearly constant mean increase rate by 0.07 mm per month. The corresponding monthly elongation rate of total CIA length was 0.26 mm at 24 months and 0.34 mm at 5 years (p < 0.001). The respective monthly lengthening of CIAs' uncovered (from stent graft) segment was 0.10 and 0.15 mm, and the overall increase rate at 60 months was up to 53.9% (p < 0.001). A total of 20 EVAR-related events were recorded, and multivariate analysis revealed that CIA dilatation served as a significant and independent predictor of long-term EVAR failures, increasing the likelihood of adverse events by 2.8-fold. Conclusions: Analysis of long-term geometric CIA remodeling after a standard EVAR revealed a significant progression of aneurysmal disease in CIAs, which was associated with worsening EVAR outcomes and emphasizes the importance of a rigorous and extensive follow-up protocol to maintain the long-term EVAR effectiveness.

导论:EVAR后髂总动脉(cia)动脉瘤疾病的进展仍然是一个研究不足的领域。本研究的目的是研究标准选择性EVAR与各种上一代分叉主动脉内移植物与cia动脉瘤疾病进展的长期结果。方法:这是一项前瞻性队列研究,168例患者在2013年至2018年期间接受了6种不同的内移植物治疗,并完成了5年的计算机断层主动脉血管造影(CTA)随访。术后CTA分析包括术后第1个月、第24个月和第60个月三个时间点的四个直径点和两个长度水平的CIA测量。记录所有与evar相关的不良事件,包括迁移、内漏、肢体闭塞、再干预、破裂和死亡率。结果:在两个时间间隔内,心肌的扩张和伸长均呈明显的近似线性。在所有测量的直径点中,24个月时的平均增长率为11.7%,60个月时的平均增长率为22.8% (p < 0.001),平均增长率为0.07 mm /月。CIA总长度对应的月延长率为0.26 mm(24个月)和0.34 mm(5年)(p < 0.001)。CIAs未覆盖(来自支架)段的月延长分别为0.10和0.15 mm, 60个月时的总增长率高达53.9% (p < 0.001)。共记录了20例EVAR相关事件,多变量分析显示,CIA扩张是长期EVAR失败的重要独立预测因子,使不良事件发生的可能性增加2.8倍。结论:对标准EVAR后长期CIA几何重构的分析显示,CIA中动脉瘤疾病的显著进展与EVAR结果恶化有关,强调了严格和广泛的随访方案对维持EVAR长期有效性的重要性。
{"title":"The Long-Term Progression of Aneurysmal Disease in Common Iliac Arteries After Standard EVAR and Its Clinical Implications.","authors":"Apostolos G Pitoulias, Dimitrios Chatzelas, Matthaios G Pitoulias, Loukia A Politi, Dimitrios C Christopoulos, Ioannis Lazaridis, Nikolaos Saratzis, Georgios A Pitoulias","doi":"10.1155/ijvm/4229582","DOIUrl":"10.1155/ijvm/4229582","url":null,"abstract":"<p><p><b>Introduction:</b> The progression of aneurysmal disease in the common iliac arteries (CIAs) after EVAR remains an insufficiently investigated field. The purpose of this study is to investigate the long-term outcomes of standard elective EVAR with a variety of last-generation bifurcated aortic endografts in relation with the progression of aneurysmal disease in the CIAs. <b>Methods:</b> This is a prospective cohort study of 168 patients, who were treated with six different endografts between 2013 and 2018 and completed the 5-year computed tomography aortoangiography (CTA) follow-up. Postoperative CTA analysis included CIA measurements at four diameters' points and two length levels in three postoperative time spots: first, 24th, and 60th months. All EVAR-related adverse events were recorded, including migrations, endoleaks, limb occlusions, reinterventions, ruptures, and mortality. <b>Results:</b> At both time intervals, a significant and nearly linear dilatation and elongation of CIAs was evident. The mean percent increase, among all diameter points measured, was 11.7% at 24 months and 22.8% at 60 months (<i>p</i> < 0.001) with a nearly constant mean increase rate by 0.07 mm per month. The corresponding monthly elongation rate of total CIA length was 0.26 mm at 24 months and 0.34 mm at 5 years (<i>p</i> < 0.001). The respective monthly lengthening of CIAs' uncovered (from stent graft) segment was 0.10 and 0.15 mm, and the overall increase rate at 60 months was up to 53.9% (<i>p</i> < 0.001). A total of 20 EVAR-related events were recorded, and multivariate analysis revealed that CIA dilatation served as a significant and independent predictor of long-term EVAR failures, increasing the likelihood of adverse events by 2.8-fold. <b>Conclusions:</b> Analysis of long-term geometric CIA remodeling after a standard EVAR revealed a significant progression of aneurysmal disease in CIAs, which was associated with worsening EVAR outcomes and emphasizes the importance of a rigorous and extensive follow-up protocol to maintain the long-term EVAR effectiveness.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"4229582"},"PeriodicalIF":2.5,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142800685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Brachial Compression Versus Ulnar Compression on Radial Artery Diameter: A Randomized Controlled Trial. 肱动脉压迫与尺动脉压迫对桡动脉直径的影响比较:随机对照试验
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9965794
Fatemeh Bahrami, Shayan Mirshafiee, Pejman Mansouri, Mohammadreza Eftekhari, Mohammad Vahidi, Fateme Baharvand, Ehsan Moradi Farsani, Hamed Vahidi

Objectives: This study is aimed at comparing the effectiveness of ulnar compression and brachial compression in inducing radial artery dilatation. Methods: This randomized crossover study included 30 patients undergoing elective diagnostic transradial coronary angiography. Ulnar compression and brachial compression maneuvers were performed in two groups. Radial artery diameter and cross-sectional area were measured at baseline and remeasured every 30 s (up to 2 min) after the interventions. Results: Both ulnar compression and brachial compression maneuvers successfully increased radial artery diameter for up to 60 s following the interventions. There were no statistically significant differences between the two groups after adjusting for baseline measurements. However, each treatment group showed a significant increase in indicators up to 60 s, followed by a subsequent decrease. The maximum radial artery diameter occurred at 60 s after the removal of compression in both groups. Conclusion: Ulnar compression and brachial compression maneuvers demonstrated effectiveness in inducing radial artery dilation for a limited duration. These maneuvers may reduce the occurrence of access failure during radial artery cannulation. No significant differences were observed between the two maneuvers, indicating that they can be used interchangeably based on clinician preference. So, because the ulnar compression is simpler and more feasible for the patients, it can be considered instead of brachial compression. Trial Registration: IRCT20230209057372N1.

研究目的本研究旨在比较尺骨压迫和肱骨压迫在诱导桡动脉扩张方面的效果。方法:随机交叉研究:这项随机交叉研究包括 30 名接受择期经桡动脉冠状动脉造影诊断的患者。两组患者分别进行了尺动脉压迫和肱动脉压迫操作。基线时测量桡动脉直径和横截面积,干预后每隔 30 秒(最长 2 分钟)重新测量一次。结果:尺骨压迫和肱动脉压迫均能在干预后 60 秒内成功增加桡动脉直径。在调整基线测量值后,两组之间没有明显的统计学差异。不过,每个治疗组的指标在 60 秒内都有显著增加,随后又有所减少。两组的最大桡动脉直径都出现在解除压迫后的 60 秒。结论尺骨压迫和肱骨压迫手法在诱导桡动脉扩张方面具有一定的有效性。这些方法可减少桡动脉插管过程中出现的通路失败。两种手法之间没有明显差异,这表明它们可以根据临床医生的偏好交替使用。因此,由于尺动脉压迫对患者来说更简单可行,可以考虑用它来代替肱动脉压迫。试验注册:IRCT20230209057372N1.
{"title":"Comparison of Brachial Compression Versus Ulnar Compression on Radial Artery Diameter: A Randomized Controlled Trial.","authors":"Fatemeh Bahrami, Shayan Mirshafiee, Pejman Mansouri, Mohammadreza Eftekhari, Mohammad Vahidi, Fateme Baharvand, Ehsan Moradi Farsani, Hamed Vahidi","doi":"10.1155/2024/9965794","DOIUrl":"10.1155/2024/9965794","url":null,"abstract":"<p><p><b>Objectives:</b> This study is aimed at comparing the effectiveness of ulnar compression and brachial compression in inducing radial artery dilatation. <b>Methods:</b> This randomized crossover study included 30 patients undergoing elective diagnostic transradial coronary angiography. Ulnar compression and brachial compression maneuvers were performed in two groups. Radial artery diameter and cross-sectional area were measured at baseline and remeasured every 30 s (up to 2 min) after the interventions. <b>Results:</b> Both ulnar compression and brachial compression maneuvers successfully increased radial artery diameter for up to 60 s following the interventions. There were no statistically significant differences between the two groups after adjusting for baseline measurements. However, each treatment group showed a significant increase in indicators up to 60 s, followed by a subsequent decrease. The maximum radial artery diameter occurred at 60 s after the removal of compression in both groups. <b>Conclusion:</b> Ulnar compression and brachial compression maneuvers demonstrated effectiveness in inducing radial artery dilation for a limited duration. These maneuvers may reduce the occurrence of access failure during radial artery cannulation. No significant differences were observed between the two maneuvers, indicating that they can be used interchangeably based on clinician preference. So, because the ulnar compression is simpler and more feasible for the patients, it can be considered instead of brachial compression. <b>Trial Registration:</b> IRCT20230209057372N1.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"9965794"},"PeriodicalIF":2.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing Cardiovascular Disease Research in the Arab Region: A Bibliometric Review From 2012 to 2022. 分析阿拉伯地区的心血管疾病研究:2012 年至 2022 年文献计量学回顾》。
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-12 eCollection Date: 2024-01-01 DOI: 10.1155/2024/5915132
Amjad Bani Hani, Alaa Tarazi, Yazan Hamadneh, Ahmad Al-Samahan, Rami Awad, Mohammad Kan'an, Mohammad Al-Kasaji, Nidal A Younes

Background: Cardiovascular diseases (CVDs) remain the leading cause of mortality, especially in low- and middle-income countries, many of which are in the Arab region. We aimed to conduct a bibliometric analysis to assess the scientific output concerning CVDs in the Arab region and the Middle East over the past decade. Methods: A bibliometric search was conducted on PubMed and Scopus between 2012 and 2022. The study analyzed the number of publications, countries, institutional sources, authors, journals, and keywords. Visualization analysis was executed using various software tools, including R, VOSviewer, and CiteSpace. Results: PubMed and Scopus yielded 5340 documents related to CVDs at the time of data collection. A total of 1263 documents were retrieved after screening based on specific inclusion criteria that guarantee the inclusion only for Arab region studies and authors. There has been a consistent increase in annual publications in recent years. The countries that contributed the most to research in this field were Egypt, Saudi Arabia, and the UAE. Although Egypt stood out as the most productive country, the institute with the highest number of documents was in Qatar. In addition, the Top 3 authors hailed from Qatar. Saudi Medical Journal leads the field as the most productive journal, followed closely by PLoS One and Angiology. Research topics of significant interest in the realm of CVDs include specific diseases such as heart failure, risk factors related to CVDs, genetic aspects of CVDs, and congenital disorders in infant's cardiac health. Conclusion: This study provides a comprehensive overview of the current status of CVD research in the Arab region. It includes research hotspots that can guide authors in determining the necessary future investigations within this field. There is a clear call for further exploration of various aspects of CVDs in the Arab world. Strengthening cooperation between countries and institutes is needed.

背景:心血管疾病(CVDs)仍然是导致死亡的主要原因,尤其是在中低收入国家,其中许多国家位于阿拉伯地区。我们旨在进行文献计量分析,以评估过去十年阿拉伯地区和中东有关心血管疾病的科学成果。方法:我们在 PubMed 和 Scopus 上进行了文献计量学检索,检索时间为 2012 年至 2022 年。研究分析了出版物的数量、国家、机构来源、作者、期刊和关键词。使用各种软件工具(包括 R、VOSviewer 和 CiteSpace)进行了可视化分析。结果在收集数据时,PubMed 和 Scopus 共收录了 5340 篇与心血管疾病相关的文献。根据特定的纳入标准(保证只纳入阿拉伯地区的研究和作者)进行筛选后,共检索到 1263 篇文献。近年来,每年发表的论文数量持续增长。对该领域研究贡献最大的国家是埃及、沙特阿拉伯和阿联酋。虽然埃及是成果最多的国家,但文献数量最多的机构却是卡塔尔。此外,前三名作者均来自卡塔尔。沙特医学杂志》是该领域产量最高的期刊,《PLoS One》和《血管病学》紧随其后。心血管疾病领域的重要研究课题包括心力衰竭等特定疾病、与心血管疾病相关的风险因素、心血管疾病的遗传因素以及婴儿心脏健康的先天性疾病。结论本研究全面概述了阿拉伯地区心血管疾病的研究现状。它包括一些研究热点,可指导作者确定该领域未来必要的调查。显然,阿拉伯世界需要进一步探索气相化学变化的各个方面。需要加强国家和机构之间的合作。
{"title":"Analyzing Cardiovascular Disease Research in the Arab Region: A Bibliometric Review From 2012 to 2022.","authors":"Amjad Bani Hani, Alaa Tarazi, Yazan Hamadneh, Ahmad Al-Samahan, Rami Awad, Mohammad Kan'an, Mohammad Al-Kasaji, Nidal A Younes","doi":"10.1155/2024/5915132","DOIUrl":"10.1155/2024/5915132","url":null,"abstract":"<p><p><b>Background:</b> Cardiovascular diseases (CVDs) remain the leading cause of mortality, especially in low- and middle-income countries, many of which are in the Arab region. We aimed to conduct a bibliometric analysis to assess the scientific output concerning CVDs in the Arab region and the Middle East over the past decade. <b>Methods:</b> A bibliometric search was conducted on PubMed and Scopus between 2012 and 2022. The study analyzed the number of publications, countries, institutional sources, authors, journals, and keywords. Visualization analysis was executed using various software tools, including R, VOSviewer, and CiteSpace. <b>Results:</b> PubMed and Scopus yielded 5340 documents related to CVDs at the time of data collection. A total of 1263 documents were retrieved after screening based on specific inclusion criteria that guarantee the inclusion only for Arab region studies and authors. There has been a consistent increase in annual publications in recent years. The countries that contributed the most to research in this field were Egypt, Saudi Arabia, and the UAE. Although Egypt stood out as the most productive country, the institute with the highest number of documents was in Qatar. In addition, the Top 3 authors hailed from Qatar. Saudi Medical Journal leads the field as the most productive journal, followed closely by PLoS One and Angiology. Research topics of significant interest in the realm of CVDs include specific diseases such as heart failure, risk factors related to CVDs, genetic aspects of CVDs, and congenital disorders in infant's cardiac health. <b>Conclusion:</b> This study provides a comprehensive overview of the current status of CVD research in the Arab region. It includes research hotspots that can guide authors in determining the necessary future investigations within this field. There is a clear call for further exploration of various aspects of CVDs in the Arab world. Strengthening cooperation between countries and institutes is needed.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"5915132"},"PeriodicalIF":2.5,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Clinical and Imaging Findings in Patients with Lower Extremity Varicose Veins Treated with Endovenous Laser Treatment: A Follow-Up Study of up to 12 Years. 静脉腔内激光治疗下肢静脉曲张患者的长期临床和成像结果:长达 12 年的随访研究。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-02-06 eCollection Date: 2024-01-01 DOI: 10.1155/2024/6829868
Hossein Ghanaati, Amir Hossein Jalali, Madjid Shakiba, Diana Zarei, Nafiseh Ghavami, Kavous Firouznia

Introduction: This study investigates the long-term effectiveness and safety of endovenous laser treatment (EVLT) for chronic venous insufficiency (CVI), a condition commonly caused by dysfunctional valves in the venous circulation system.

Materials and methods: In this retrospective cohort study, patients underwent EVLT and were followed up for successive short intervals and one last time after a median duration of 9-year postprocedural. Pre- and postprocedure duplex ultrasound was used to assess changes in the great saphenous vein (GSV) diameter, reflux, and saphenofemoral junction incompetence. Quality of life was evaluated using the SF-36 and Aberdeen Varicose Vein Questionnaire (AVVQ).

Results: Sixty-eight patients with a mean age of 52.4 ± 12.4 years were enrolled in the study. The mean follow-up time was 8.9 ± 2.1 years, ranging from 5 to 12 years. The mean GSV diameter significantly decreased in all patients (whole group) across proximal (from 5.8 ± 2.3 mm to 4.2 ± 2.1 mm), middle (from 4.7 ± 1.6 mm to 2.8 ± 2.2 mm), and distal (from 4.5 ± 2.3 mm to 2.2 ± 2.2 mm) segments, with P < 0.001. A disease recurrence rate of 33.8% was noted, predominantly in male patients and those with larger middle GSV diameters (OR = 5.2 (95%CI = 1.3-20.4) and OR = 1.5 (95%CI = 1-2.1), respectively). The average follow-up time for patients without recurrence was 8.8 ± 2.1 years. Almost half of the patients without recurrence were followed up for 10 years or more (49%).

Conclusion: The efficacy of EVLT in managing varicose veins is demonstrated by its relatively low recurrence rate over a 10-year follow-up period, highlighting EVLT as a viable long-term treatment strategy.

简介:慢性静脉功能不全(CVI)是由静脉循环系统中的瓣膜功能失调引起的一种常见疾病,本研究调查了静脉腔内激光治疗(EVLT)的长期有效性和安全性:在这项回顾性队列研究中,患者接受了 EVLT 治疗,并在术后接受了连续的短期随访和最后一次随访,中位随访时间为术后 9 年。术前和术后双工超声用于评估大隐静脉(GSV)直径、回流和隐股交界处闭锁的变化。使用 SF-36 和阿伯丁静脉曲张问卷(AVVQ)评估生活质量:研究共纳入 68 名患者,平均年龄为(52.4 ± 12.4)岁。平均随访时间为 8.9 ± 2.1 年,从 5 年到 12 年不等。所有患者(全组)的近段(从 5.8 ± 2.3 mm 到 4.2 ± 2.1 mm)、中段(从 4.7 ± 1.6 mm 到 2.8 ± 2.2 mm)和远段(从 4.5 ± 2.3 mm 到 2.2 ± 2.2 mm)的平均 GSV 直径均明显缩小,P < 0.001。疾病复发率为 33.8%,主要发生在男性患者和 GSV 中段直径较大的患者中(OR = 5.2 (95%CI = 1.3-20.4) 和 OR = 1.5 (95%CI = 1-2.1))。未复发患者的平均随访时间为 8.8 ± 2.1 年。近一半未复发的患者接受了 10 年或更长时间的随访(49%):结论:EVLT治疗静脉曲张的疗效体现在其10年随访期间相对较低的复发率上,突出表明EVLT是一种可行的长期治疗策略。
{"title":"Long-Term Clinical and Imaging Findings in Patients with Lower Extremity Varicose Veins Treated with Endovenous Laser Treatment: A Follow-Up Study of up to 12 Years.","authors":"Hossein Ghanaati, Amir Hossein Jalali, Madjid Shakiba, Diana Zarei, Nafiseh Ghavami, Kavous Firouznia","doi":"10.1155/2024/6829868","DOIUrl":"10.1155/2024/6829868","url":null,"abstract":"<p><strong>Introduction: </strong>This study investigates the long-term effectiveness and safety of endovenous laser treatment (EVLT) for chronic venous insufficiency (CVI), a condition commonly caused by dysfunctional valves in the venous circulation system.</p><p><strong>Materials and methods: </strong>In this retrospective cohort study, patients underwent EVLT and were followed up for successive short intervals and one last time after a median duration of 9-year postprocedural. Pre- and postprocedure duplex ultrasound was used to assess changes in the great saphenous vein (GSV) diameter, reflux, and saphenofemoral junction incompetence. Quality of life was evaluated using the SF-36 and Aberdeen Varicose Vein Questionnaire (AVVQ).</p><p><strong>Results: </strong>Sixty-eight patients with a mean age of 52.4 ± 12.4 years were enrolled in the study. The mean follow-up time was 8.9 ± 2.1 years, ranging from 5 to 12 years. The mean GSV diameter significantly decreased in all patients (whole group) across proximal (from 5.8 ± 2.3 mm to 4.2 ± 2.1 mm), middle (from 4.7 ± 1.6 mm to 2.8 ± 2.2 mm), and distal (from 4.5 ± 2.3 mm to 2.2 ± 2.2 mm) segments, with <i>P</i> < 0.001. A disease recurrence rate of 33.8% was noted, predominantly in male patients and those with larger middle GSV diameters (OR = 5.2 (95%CI = 1.3-20.4) and OR = 1.5 (95%CI = 1-2.1), respectively). The average follow-up time for patients without recurrence was 8.8 ± 2.1 years. Almost half of the patients without recurrence were followed up for 10 years or more (49%).</p><p><strong>Conclusion: </strong>The efficacy of EVLT in managing varicose veins is demonstrated by its relatively low recurrence rate over a 10-year follow-up period, highlighting EVLT as a viable long-term treatment strategy.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"6829868"},"PeriodicalIF":1.3,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10864052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiopoietin-2 Is Associated with Aortic Stiffness in Diabetes Patients in Ghana: A Case-Control Study. 加纳糖尿病患者血管生成素-2与主动脉硬化相关:一项病例对照研究。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-10-12 eCollection Date: 2023-01-01 DOI: 10.1155/2023/3155982
Jennifer A Agyekum, Kwame Yeboah

Objective: Impaired angiogenesis, measured as serum levels of angiogenic growth factors, may be among the mechanisms underlining aortic stiffness in diabetes patients. We studied the association between aortic stiffness and circulating angiogenic growth factors in type 2 diabetes (T2DM) patients without any organ damage.

Methods: In a case-control design, aortic pulse wave velocity (PWV), augmentation index (AIx), and aortic blood pressures (BPs) were measured in 140 T2DM patients and 110 nondiabetic controls. Fasting blood samples were collected to measure the levels of angiopoietin- (Ang-) 1, Ang-2, and vascular endothelial growth factor-A (VEGF).

Results: Compared to nondiabetes participants, T2DM patients had increased PWV (8.7 ± 1.5 vs. 7.6 ± 1.3, p = 0.031), aortic pulse BP (58 ± 20 vs. 49 ± 17, p = 0.011), Ang-2 (838 (473-1241) vs. 597 (274-1005), p = 0.018), and VEGF (72.2 (28-201.8) vs. 48.4 (17.4-110.1), p = 0.025) but reduced levels of AIx (21.7 ± 13.8 vs. 34 ± 12.9, p < 0.001) and Ang-1 (33.1 (24.7-42.1) vs. 41.1 (30-57.3), p = 0.01). In all study participants, compared to those in the lower tertile, participants in the upper tertile of Ang-2 had increased odds of PWV (2.01 (1.17-3.84), p = 0.004), aortic systolic BP (1.24 (1.04-1.97), p = 0.011), and aortic pulse BP (1.19 (1.04-1.82), p = 0.041) but reduced odds of AIx (0.84 (0.71-0.96), p = 0.014) in multivariable-adjusted models.

Conclusion: In our study population, increased circulating Ang-2 was associated with increased levels of aortic stiffness parameters.

目的:血管生成受损,以血管生成生长因子的血清水平衡量,可能是糖尿病患者主动脉硬化的机制之一。我们研究了在没有任何器官损伤的2型糖尿病(T2DM)患者中主动脉硬化与循环血管生成生长因子之间的关系。方法:在病例对照设计中,测量140名T2DM患者和110名非糖尿病对照的主动脉脉搏波速度(PWV)、增宽指数(AIx)和主动脉血压(BP)。采集空腹血样以测量血管生成素-(Ang-)1、Ang-2和血管内皮生长因子-A(VEGF)的水平。结果:与非糖尿病参与者相比,T2DM患者的PWV(8.7±1.5 vs.7.6±1.3,p=0.031)、主动脉脉压(58±20 vs.49±17,p=0.011)、Ang-2(838(473-1241)vs.597(274-1005),p=0.018)增加,和VEGF(72.2(28-201.8)vs.48.4(17.4-110.1),p=0.025),但AIx水平降低(21.7±13.8 vs.34±12.9,p<0.001)和Ang-1水平降低(33.1(24.7-42.1)vs.41.1(30-57.3),p=0.01)。在所有研究参与者中,与下三分位数的参与者相比,Ang-2上三分位数参与者的PWV(2.01(1.17-3.84),p=0.004)、主动脉收缩压(1.24(1.04-1.97),p=0.011)和主动脉脉搏BP(1.19(1.04-1.82),p=0.041),但在多变量调整模型中AIx的几率降低(0.84(0.71-0.96),p=0.014)。结论:在我们的研究人群中,循环Ang-2的增加与主动脉硬化参数水平的增加有关。
{"title":"Angiopoietin-2 Is Associated with Aortic Stiffness in Diabetes Patients in Ghana: A Case-Control Study.","authors":"Jennifer A Agyekum,&nbsp;Kwame Yeboah","doi":"10.1155/2023/3155982","DOIUrl":"10.1155/2023/3155982","url":null,"abstract":"<p><strong>Objective: </strong>Impaired angiogenesis, measured as serum levels of angiogenic growth factors, may be among the mechanisms underlining aortic stiffness in diabetes patients. We studied the association between aortic stiffness and circulating angiogenic growth factors in type 2 diabetes (T2DM) patients without any organ damage.</p><p><strong>Methods: </strong>In a case-control design, aortic pulse wave velocity (PWV), augmentation index (AIx), and aortic blood pressures (BPs) were measured in 140 T2DM patients and 110 nondiabetic controls. Fasting blood samples were collected to measure the levels of angiopoietin- (Ang-) 1, Ang-2, and vascular endothelial growth factor-A (VEGF).</p><p><strong>Results: </strong>Compared to nondiabetes participants, T2DM patients had increased PWV (8.7 ± 1.5 vs. 7.6 ± 1.3, <i>p</i> = 0.031), aortic pulse BP (58 ± 20 vs. 49 ± 17, <i>p</i> = 0.011), Ang-2 (838 (473-1241) vs. 597 (274-1005), <i>p</i> = 0.018), and VEGF (72.2 (28-201.8) vs. 48.4 (17.4-110.1), <i>p</i> = 0.025) but reduced levels of AIx (21.7 ± 13.8 vs. 34 ± 12.9, <i>p</i> < 0.001) and Ang-1 (33.1 (24.7-42.1) vs. 41.1 (30-57.3), <i>p</i> = 0.01). In all study participants, compared to those in the lower tertile, participants in the upper tertile of Ang-2 had increased odds of PWV (2.01 (1.17-3.84), <i>p</i> = 0.004), aortic systolic BP (1.24 (1.04-1.97), <i>p</i> = 0.011), and aortic pulse BP (1.19 (1.04-1.82), <i>p</i> = 0.041) but reduced odds of AIx (0.84 (0.71-0.96), <i>p</i> = 0.014) in multivariable-adjusted models.</p><p><strong>Conclusion: </strong>In our study population, increased circulating Ang-2 was associated with increased levels of aortic stiffness parameters.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2023 ","pages":"3155982"},"PeriodicalIF":1.3,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49690485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerobic Exercise versus Electronic Cigarette in Vascular Aging Process: First Histological Insight. 有氧运动与电子烟在血管老化过程中的作用:第一次组织学观察。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-01-01 DOI: 10.1155/2023/8874599
Vito A Damay, Setiawan, Ronny Lesmana, Muhammad Rizki Akbar, Antonia Anna Lukito, Vita M Tarawan, Januar W Martha, J Nugroho, Sony Sugiharto

Smoking is related to vascular aging. However, the hazardous effect of e-cigarette is often debatable, with limited studies available. In contrast, moderate-intensity aerobic exercise is well known to decrease aortic stiffness. We provide novel research to determine the effect of e-cigarette and aerobic moderate-intensity exercise on the aortic structure of Wistar rats. A total of 26 male Wistar rats (Rattus norvegicus) 8 weeks aged, 200-250 g b.w., were randomly divided into 4 groups, namely, K0 (normal rats), K1 (rats were given moderate-intensity aerobic exercise by animal treadmill 20 m/30 min), K2 (rats were given e-cigarette with 6 mg nicotine, 40% propylene glycol, and 60% vegetable glycerine 30 min for 5 days/week), and K3 (rats were given e-cigarette and moderate-intensity aerobic exercise). After exposure for 6 weeks, all animals were sacrificed to isolate the aorta for histopathological analysis with hematoxylin-eosin stain to evaluate the elastic fiber layer and intimal-medial thickness. The Verhoeff-Van Gieson staining was done for quantification elastic lamina fragmentation. Our study found that the e-cigarette group had the highest elastic lamina fragmentation among groups (8.14 ± 2.85). The exercise only group showed the lowest elastic lamina fragmentation (2.50 ± 1.87). Fragmentation in the e-cigarette and exercise group was higher than in the exercise only group (5.83 ± 0.753 vs. 2.50 ± 1.87, p = 0.002). There is a significant difference of NO serum between four groups. The result of post hoc analysis using LSD showed that there is a significant difference of NO serum between K0 and K2, K0 and K3, K1 and K2, and K1 and K3. Therefore, our research demonstrated that the most injury of aorta elastic lamina was in the group that was exposed to e-cigarette that leads to vascular aging while exercise is not yet proven to reverse this effect.

吸烟与血管老化有关。然而,电子烟的有害影响往往是有争议的,可用的研究有限。相反,中等强度的有氧运动可以减少主动脉僵硬。我们提供了新的研究来确定电子烟和有氧中等强度运动对Wistar大鼠主动脉结构的影响。选取雄性褐家鼠(Rattus norvegicus) 26只,8周龄,200-250 g b.w.,随机分为4组,K0组(正常大鼠),K1组(在动物跑步机上进行20 m/30 min的中等强度有氧运动),K2组(给予尼古丁6 mg、40%丙二醇和60%植物甘油30 min的电子烟,连续5天/周),K3组(给予电子烟和中等强度有氧运动)。暴露6周后处死分离主动脉,用苏木精-伊红染色法进行组织病理学分析,评估弹性纤维层和内膜-内侧厚度。verhoefff - van Gieson染色定量测定弹性板断裂。我们的研究发现,电子烟组的弹性层裂率最高(8.14±2.85)。运动组弹性椎板碎裂率最低(2.50±1.87)。电子烟和运动组的碎片化程度高于运动组(5.83±0.753 vs. 2.50±1.87,p = 0.002)。四组间血清NO含量差异有统计学意义。LSD事后分析结果显示,血清NO在K0与K2、K0与K3、K1与K2、K1与K3之间存在显著差异。因此,我们的研究表明,主动脉弹性板损伤最严重的是电子烟暴露组,导致血管老化,而运动尚未被证明可以逆转这种影响。
{"title":"Aerobic Exercise versus Electronic Cigarette in Vascular Aging Process: First Histological Insight.","authors":"Vito A Damay,&nbsp;Setiawan,&nbsp;Ronny Lesmana,&nbsp;Muhammad Rizki Akbar,&nbsp;Antonia Anna Lukito,&nbsp;Vita M Tarawan,&nbsp;Januar W Martha,&nbsp;J Nugroho,&nbsp;Sony Sugiharto","doi":"10.1155/2023/8874599","DOIUrl":"https://doi.org/10.1155/2023/8874599","url":null,"abstract":"<p><p>Smoking is related to vascular aging. However, the hazardous effect of e-cigarette is often debatable, with limited studies available. In contrast, moderate-intensity aerobic exercise is well known to decrease aortic stiffness. We provide novel research to determine the effect of e-cigarette and aerobic moderate-intensity exercise on the aortic structure of Wistar rats. A total of 26 male Wistar rats (Rattus norvegicus) 8 weeks aged, 200-250 g b.w., were randomly divided into 4 groups, namely, K0 (normal rats), K1 (rats were given moderate-intensity aerobic exercise by animal treadmill 20 m/30 min), K2 (rats were given e-cigarette with 6 mg nicotine, 40% propylene glycol, and 60% vegetable glycerine 30 min for 5 days/week), and K3 (rats were given e-cigarette and moderate-intensity aerobic exercise). After exposure for 6 weeks, all animals were sacrificed to isolate the aorta for histopathological analysis with hematoxylin-eosin stain to evaluate the elastic fiber layer and intimal-medial thickness. The Verhoeff-Van Gieson staining was done for quantification elastic lamina fragmentation. Our study found that the e-cigarette group had the highest elastic lamina fragmentation among groups (8.14 ± 2.85). The exercise only group showed the lowest elastic lamina fragmentation (2.50 ± 1.87). Fragmentation in the e-cigarette and exercise group was higher than in the exercise only group (5.83 ± 0.753 vs. 2.50 ± 1.87, <i>p</i> = 0.002). There is a significant difference of NO serum between four groups. The result of post hoc analysis using LSD showed that there is a significant difference of NO serum between K0 and K2, K0 and K3, K1 and K2, and K1 and K3. Therefore, our research demonstrated that the most injury of aorta elastic lamina was in the group that was exposed to e-cigarette that leads to vascular aging while exercise is not yet proven to reverse this effect.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2023 ","pages":"8874599"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9935870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia. 哥伦比亚COVID-19大流行期间医院层面与QT间期延长相关的药物使用
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-09-21 eCollection Date: 2022-01-01 DOI: 10.1155/2022/3045942
Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Carlos Fernando Tovar-Yepes, Jorge Enrique Machado-Alba

Background: Many of the therapeutic proposals for COVID-19 have been associated with adverse effects, including the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of drugs with a risk of QT interval prolongation in 21 clinics/hospitals in Colombia from January to December 2020.

Methods: This cross-sectional study identified drug use according to pharmacological groups with potential risk of QT interval prolongation according to a risk classification: conditional, possible, and known risk of TdP. Descriptive analyses were performed.

Results: A total of 355,574 patients who received QT-prolonging drugs were identified (equivalent to 51.4% of all inpatients treated during the study period). Of the group of patients on QT drugs, 54.4% used at least one drug with conditional risk, 52.6% with possible risk, and 40.3% with known risk. The most commonly used belonged to the group of drugs for the nervous system (63.0%), alimentary tract and metabolism (56.8%), anti-infectives for systemic use (13.0%), and the cardiovascular system (11.7%). On average, patients received 2.0 ± 1.5 risk drugs. Regarding drugs initially considered against COVID-19, 2,120 patients (0.6%) received azithromycin, 802 (0.2%) received chloroquine, 517 received hydroxychloroquine (0.1%), and 265 received lopinavir/ritonavir (0.1%).

Conclusion: The high proportion of patients treated at the hospital level who receive drugs with risk of prolonging the QT interval should alert those responsible for their care to avoid fatal outcomes, especially during the COVID-19 epidemic, when some QT drugs are being used more frequently.

背景:许多针对COVID-19的治疗方案都与不良反应相关,包括QT间期延长和点扭转(TdP)的风险。目的是确定2020年1月至12月期间哥伦比亚21家诊所/医院中存在QT间期延长风险的药物使用情况。方法:本横断面研究根据具有QT间期延长潜在风险的药理学组,根据TdP的风险分类:有条件的、可能的和已知的风险,确定药物使用。进行描述性分析。结果:共有355,574例患者接受了延长qt的药物治疗(相当于研究期间所有住院患者的51.4%)。在QT药物组中,54.4%的患者至少使用一种有条件风险的药物,52.6%有可能风险,40.3%有已知风险。使用最多的是神经系统(63.0%)、消化道和代谢(56.8%)、全身抗感染(13.0%)和心血管系统(11.7%)。患者平均使用2.0±1.5种危险药物。在初步考虑的抗新冠肺炎药物中,阿奇霉素2120例(0.6%),氯喹802例(0.2%),羟氯喹517例(0.1%),洛匹那韦/利托那韦265例(0.1%)。结论:在医院接受治疗的患者中,使用有延长QT间期风险的药物的比例很高,应提醒负责其护理的人员避免致命的后果,特别是在COVID-19流行期间,当一些QT间期药物使用更频繁时。
{"title":"Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia.","authors":"Andrés Gaviria-Mendoza,&nbsp;Manuel Enrique Machado-Duque,&nbsp;Luis Fernando Valladales-Restrepo,&nbsp;Carlos Fernando Tovar-Yepes,&nbsp;Jorge Enrique Machado-Alba","doi":"10.1155/2022/3045942","DOIUrl":"https://doi.org/10.1155/2022/3045942","url":null,"abstract":"<p><strong>Background: </strong>Many of the therapeutic proposals for COVID-19 have been associated with adverse effects, including the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of drugs with a risk of QT interval prolongation in 21 clinics/hospitals in Colombia from January to December 2020.</p><p><strong>Methods: </strong>This cross-sectional study identified drug use according to pharmacological groups with potential risk of QT interval prolongation according to a risk classification: conditional, possible, and known risk of TdP. Descriptive analyses were performed.</p><p><strong>Results: </strong>A total of 355,574 patients who received QT-prolonging drugs were identified (equivalent to 51.4% of all inpatients treated during the study period). Of the group of patients on QT drugs, 54.4% used at least one drug with conditional risk, 52.6% with possible risk, and 40.3% with known risk. The most commonly used belonged to the group of drugs for the nervous system (63.0%), alimentary tract and metabolism (56.8%), anti-infectives for systemic use (13.0%), and the cardiovascular system (11.7%). On average, patients received 2.0 ± 1.5 risk drugs. Regarding drugs initially considered against COVID-19, 2,120 patients (0.6%) received azithromycin, 802 (0.2%) received chloroquine, 517 received hydroxychloroquine (0.1%), and 265 received lopinavir/ritonavir (0.1%).</p><p><strong>Conclusion: </strong>The high proportion of patients treated at the hospital level who receive drugs with risk of prolonging the QT interval should alert those responsible for their care to avoid fatal outcomes, especially during the COVID-19 epidemic, when some QT drugs are being used more frequently.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":" ","pages":"3045942"},"PeriodicalIF":1.3,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40391083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy in the Treatment of Oral Vascular Malformations. 二极管激光(980 nm)与硬化疗法治疗口腔血管畸形的疗效及安全性比较。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2785859
Peeyush Shivhare, Naqoosh Haidry, Neha Sah, Ajay Kumar, Abhishek Gupta, Ankur Singh, Mohan Raju Penumatcha, Shalini Subramanyam

Background: Vascular malformations are structural abnormalities which are formed by progressively enlarging aberrant and ecstatic vessels without endothelial cell proliferation and composed of the type of vessel involved, i.e., capillary, veins, and arteriovenous. Treatment of vascular malformations may involve many techniques like sclerotherapy, embolization, surgical resection, cryotherapy, laser treatment, or medical therapy. This observational prospective study is aimed at evaluating and comparing the effects and efficacy of diode laser and sclerotherapy in the treatment of oral vascular malformation.

Materials and methods: 40 patients presenting with oral vascular malformation were included in the present study. The patients were divided equally (20 in each) into two groups, i.e., the laser group and sclerotherapy group. Sclerotherapy was performed with 3% sodium tetradecyl sulfate while the laser group was treated with diode laser 980 nm with transmucosal thermophotocoagulation. The patients were assessed for the response, remission, and side effects. The results obtained were tabulated and compared with the chi-square test.

Results: Side effects were found significantly lesser in the laser group compared to the sclerotherapy group (p < 0.05). Statistically significant difference was seen for postoperative pain between two groups. The laser group had mild to moderate pain compared to severe pain in the sclerotherapy group. Recurrence was observed more in the laser group compared to the sclerotherapy group.

Conclusions: Laser and sclerotherapy with 3% sodium tetradecyl sulfate both are effective in the treatment of vascular malformations. Diode laser seems to be better than sclerotherapy given lesser side effects and comfort to the patients while sclerotherapy seems to be better in respect to recurrences.

背景:血管畸形是一种结构异常,由逐渐增大的异常血管和狂喜血管形成,无内皮细胞增殖,包括血管类型,即毛细血管、静脉和动静脉。血管畸形的治疗可能涉及许多技术,如硬化治疗、栓塞、手术切除、冷冻治疗、激光治疗或药物治疗。本观察性前瞻性研究旨在评价和比较二极管激光和硬化疗法治疗口腔血管畸形的效果和疗效。材料与方法:选取40例口腔血管畸形患者作为研究对象。将患者平均分为两组,即激光组和硬化治疗组,每组20例。采用3%硫酸十四烷基钠进行硬化治疗,激光组采用980 nm二极管激光经粘膜热光凝治疗。评估患者的反应、缓解和副作用。将所得结果制成表格,并用卡方检验进行比较。结果:激光治疗组不良反应明显低于硬化治疗组(p < 0.05)。两组术后疼痛差异有统计学意义。与硬化治疗组的严重疼痛相比,激光组有轻度至中度疼痛。与硬化治疗组相比,激光治疗组的复发率更高。结论:激光和3%硫酸十四烷基钠硬化治疗血管畸形均有较好的疗效。二极管激光似乎比硬化疗法更好,副作用更小,患者更舒适,而硬化疗法在复发方面似乎更好。
{"title":"Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy in the Treatment of Oral Vascular Malformations.","authors":"Peeyush Shivhare,&nbsp;Naqoosh Haidry,&nbsp;Neha Sah,&nbsp;Ajay Kumar,&nbsp;Abhishek Gupta,&nbsp;Ankur Singh,&nbsp;Mohan Raju Penumatcha,&nbsp;Shalini Subramanyam","doi":"10.1155/2022/2785859","DOIUrl":"https://doi.org/10.1155/2022/2785859","url":null,"abstract":"<p><strong>Background: </strong>Vascular malformations are structural abnormalities which are formed by progressively enlarging aberrant and ecstatic vessels without endothelial cell proliferation and composed of the type of vessel involved, i.e., capillary, veins, and arteriovenous. Treatment of vascular malformations may involve many techniques like sclerotherapy, embolization, surgical resection, cryotherapy, laser treatment, or medical therapy. This observational prospective study is aimed at evaluating and comparing the effects and efficacy of diode laser and sclerotherapy in the treatment of oral vascular malformation.</p><p><strong>Materials and methods: </strong>40 patients presenting with oral vascular malformation were included in the present study. The patients were divided equally (20 in each) into two groups, i.e., the laser group and sclerotherapy group. Sclerotherapy was performed with 3% sodium tetradecyl sulfate while the laser group was treated with diode laser 980 nm with transmucosal thermophotocoagulation. The patients were assessed for the response, remission, and side effects. The results obtained were tabulated and compared with the chi-square test.</p><p><strong>Results: </strong>Side effects were found significantly lesser in the laser group compared to the sclerotherapy group (<i>p</i> < 0.05). Statistically significant difference was seen for postoperative pain between two groups. The laser group had mild to moderate pain compared to severe pain in the sclerotherapy group. Recurrence was observed more in the laser group compared to the sclerotherapy group.</p><p><strong>Conclusions: </strong>Laser and sclerotherapy with 3% sodium tetradecyl sulfate both are effective in the treatment of vascular malformations. Diode laser seems to be better than sclerotherapy given lesser side effects and comfort to the patients while sclerotherapy seems to be better in respect to recurrences.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":" ","pages":"2785859"},"PeriodicalIF":1.3,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40359661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
International Journal of Vascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1